Become A Featured Company

Medical Marijuana Continues to Expand Approved Conditions

Ryan Allway

January 25th, 2017

News, Top News

Medical Marijuana Inc. (OTC Pink: MJNA), a cannabis and hemp business development firm, recently received permission from Mexico’s health authority, COFEPRIS, to import its flagship Real Scientific Hemp Oil-X™ (RSHO-X™) to treat a cancer patient for pain associated with chemotherapy and their “general well-being” according to the prescription. The move comes a year after its subsidiary, HempMeds Mexico®, received the first-ever federal permit to import a cannabis product from the U.S. to Mexico.

“Mexico’s government and regulatory authorities are starting to recognize some of the potential benefits of cannabis/cannabinoid based therapeutics for the overall health and wellness of its people,” said Medical Marijuana Inc. CEO Dr. Stuart Titus. “We believe the potential restorative and rejuvenative benefits of CBD will soon be proven by medical science – but customers and their anecdotal evidence points toward these benefits [now].”

In this article, we will take a look at the company’s recent traction and why investors may want to consider the stock for diversified exposure to the cannabis industry.

RSHO-X™ Gains Traction

Medical Marijuana Inc. developed RSHO-X™ as a completely THC-free CBD hemp oil product that meets the rigid drug testing restrictions set forth by the World Anti-Doping Agency (“WADA”). As a result, the supplement has become a popular choice for parents of small children, first responders, competitive athletes, or anyone subject to a drug test, along with governments looking to avoid the violation of any drug laws.

In February 2016, Mexico’s COFEPRIS approved the import of RSHO-X™ on a case-by-case basis to treat serious medical conditions. The first patients to take advantage of the import capabilities included Emili Zoe – a young child suffering from West syndrome with up to 250 seizures per day. Her family imported RSHO-X™, which enabled her to dramatically reduce the frequency of seizures and improve quality of life.

The recent news of a 44-year-old breast cancer patient importing RSHO-X™ for the treatment of pain from chemotherapy represents the ongoing adoption of the product in Mexico. Perhaps more importantly, the news could represent the opening up of the market to a growing number of conditions apart from just seizure treatment. The company believes there could be a broad range of conditions that could be supported through CBD hemp oils and related products.

Diversified Exposure to Cannabis

Medical Marijuana Inc.’s core strength lies in its geographic and business line diversification, which reduces risk and increases potential long-term returns for investors. For example, the company has operations spanning pharmaceuticals to marketing, while selling to countries ranging from the United States to Mexico to Brazil. The company’s products are also already commercially-available as well given the THC-free nature of RSHO-X™.

Prior to this most recent development, CEO Dr. Stuart Titus discussed the company’s groundbreaking efforts in Latin Amerca in an exclusive interview:

The company’s portfolio of subsidiaries and partners include:

  • HempMeds – HempMeds offers mainstream marketing, sales, customer service, and logistics for the cannabis industry.
  • AXIM Biotech – AXIM Biotech is focused on the research and development of cannabinoid-based therapeutics with innovative delivery systems.
  • KannaLife – KannaLife is a bio-pharmaceutical firm with an exclusive license from the NIH to commercialize therapeutic cannabinoids.
  • KannaWay – KannaWay is a network sales and marketing company specializing in hemp-based botanical products.
  • MPS International – MPS International is a premier consulting firm specializing in security services for the cannabis industry.
  • HempMeds Brasil – HempMeds Brasil is the exclusive distributor of RSHO focused on the Brazilian marketplace.
  • HempMeds Mexico – HempMeds Mexico is the exclusive distributor of RSHO focused on the Mexican marketplace.
  • Wellness Managed Services – Wellness Managed Services provides support services to cooperatives, dispensaries, and related facilities.

Looking Ahead

Medical Marijuana Inc. (OTC Pink: MJNA) continues to expand its distribution in Mexico and around the world and draw the attention of media outlets like the International Business Times. Investors looking for diversified exposure to the cannabis industry may want to take a closer look at the stock given the expansion and increased awareness in the marketplace.

For more information, visit the company’s website at www.medicalmarijuanainc.com or check out CannabisFN’s Profile at www.cannabisfn.com/mdc/medical-marijuana-inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading